Back to
Beacon Pointe Advisors, LLC
ADMA
Showing 0 of 9 quarters
Position history for
Beacon Pointe Advisors, LLC's holdings in ADMA BIOLOGICS INC
No. Beacon Pointe Advisors exited its ADMA (Adma Biologics) position in Q2 2024. Its Q1 2024 13F listed 10,653 shares worth $70,310. Beacon Pointe Advisors first reported ADMA in Q4 2021 and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.